| Mrs Amy Tierra, ARNP, NP-C, PMHNP-BC | |
|
1103 Cleveland Ave, Mount Vernon, WA 98273-4215 | |
| (260) 336-6868 | |
| (360) 336-6866 |
| Full Name | Mrs Amy Tierra |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Psychiatric/mental Health |
| Location | 1103 Cleveland Ave, Mount Vernon, Washington |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053658724 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | AP 60331561 (Washington) | Secondary |
| 363LP0808X | Nurse Practitioner - Psychiatric/mental Health | AP60331561 (Washington) | Primary |
| Entity Name | Shifa Health Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356415327 PECOS PAC ID: 9638070501 Enrollment ID: O20040115000310 |
News Archive
Researchers at Swansea University have received £230,000 to develop the world's first smart vaccine device that will both deliver the COVID-19 vaccine and measure its efficacy through monitoring the body's associated response.
The fundamental problem is that the symptoms are very similar, or at least some are. Taking your example of IBS – this is characterised by abdominal pain, plus sometimes diarrhoea or constipation. Yet these are key symptoms of abdominal cancer!
Scientists at the Oregon National Primate Research Center at Oregon Health & Science University believe they have helped dispel the myth that late-night eating causes weight gain. The research is published in the current edition of the journal Obesity Research.
Pernix Therapeutics Holdings, Inc. (NYSE Amex: PTX), a specialty pharmaceutical company, today announced the introduction of Omeclamox-Pak®, a ten-day therapy of omeprazole delayed-release capsules (20 mg), clarithromycin tablets (500 mg) and amoxicillin capsules (500 mg) for the treatment of Helicobacter pylori (H. pylori) infection and duodenal ulcer disease (active or one-year history) to eradicate H. pylori in adult patients.
› Verified 4 days ago
| Entity Name | Copilotiq Medical Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144969767 PECOS PAC ID: 9739559014 Enrollment ID: O20230113000992 |
News Archive
Researchers at Swansea University have received £230,000 to develop the world's first smart vaccine device that will both deliver the COVID-19 vaccine and measure its efficacy through monitoring the body's associated response.
The fundamental problem is that the symptoms are very similar, or at least some are. Taking your example of IBS – this is characterised by abdominal pain, plus sometimes diarrhoea or constipation. Yet these are key symptoms of abdominal cancer!
Scientists at the Oregon National Primate Research Center at Oregon Health & Science University believe they have helped dispel the myth that late-night eating causes weight gain. The research is published in the current edition of the journal Obesity Research.
Pernix Therapeutics Holdings, Inc. (NYSE Amex: PTX), a specialty pharmaceutical company, today announced the introduction of Omeclamox-Pak®, a ten-day therapy of omeprazole delayed-release capsules (20 mg), clarithromycin tablets (500 mg) and amoxicillin capsules (500 mg) for the treatment of Helicobacter pylori (H. pylori) infection and duodenal ulcer disease (active or one-year history) to eradicate H. pylori in adult patients.
› Verified 4 days ago
| Entity Name | Copilotiq Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316527203 PECOS PAC ID: 7810392040 Enrollment ID: O20230202000354 |
News Archive
Researchers at Swansea University have received £230,000 to develop the world's first smart vaccine device that will both deliver the COVID-19 vaccine and measure its efficacy through monitoring the body's associated response.
The fundamental problem is that the symptoms are very similar, or at least some are. Taking your example of IBS – this is characterised by abdominal pain, plus sometimes diarrhoea or constipation. Yet these are key symptoms of abdominal cancer!
Scientists at the Oregon National Primate Research Center at Oregon Health & Science University believe they have helped dispel the myth that late-night eating causes weight gain. The research is published in the current edition of the journal Obesity Research.
Pernix Therapeutics Holdings, Inc. (NYSE Amex: PTX), a specialty pharmaceutical company, today announced the introduction of Omeclamox-Pak®, a ten-day therapy of omeprazole delayed-release capsules (20 mg), clarithromycin tablets (500 mg) and amoxicillin capsules (500 mg) for the treatment of Helicobacter pylori (H. pylori) infection and duodenal ulcer disease (active or one-year history) to eradicate H. pylori in adult patients.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Amy Tierra, ARNP, NP-C, PMHNP-BC 1103 Cleveland Ave, Mount Vernon, WA 98273-4215 Ph: (360) 336-6868 | Mrs Amy Tierra, ARNP, NP-C, PMHNP-BC 1103 Cleveland Ave, Mount Vernon, WA 98273-4215 Ph: (260) 336-6868 |
News Archive
Researchers at Swansea University have received £230,000 to develop the world's first smart vaccine device that will both deliver the COVID-19 vaccine and measure its efficacy through monitoring the body's associated response.
The fundamental problem is that the symptoms are very similar, or at least some are. Taking your example of IBS – this is characterised by abdominal pain, plus sometimes diarrhoea or constipation. Yet these are key symptoms of abdominal cancer!
Scientists at the Oregon National Primate Research Center at Oregon Health & Science University believe they have helped dispel the myth that late-night eating causes weight gain. The research is published in the current edition of the journal Obesity Research.
Pernix Therapeutics Holdings, Inc. (NYSE Amex: PTX), a specialty pharmaceutical company, today announced the introduction of Omeclamox-Pak®, a ten-day therapy of omeprazole delayed-release capsules (20 mg), clarithromycin tablets (500 mg) and amoxicillin capsules (500 mg) for the treatment of Helicobacter pylori (H. pylori) infection and duodenal ulcer disease (active or one-year history) to eradicate H. pylori in adult patients.
› Verified 4 days ago
Marcia Rene Kucera, ARNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1420 Roosevelt Ave Ste 4, Mount Vernon, WA 98273 Phone: 360-899-4086 Fax: 360-899-4124 | |
Elizabeth M. Holmes, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1911 E Division St, Mount Vernon, WA 98274 Phone: 360-708-9741 Fax: 360-588-4192 | |
Katherine Jane Lepere, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 2101 Little Mountain Ln, Mount Vernon, WA 98274 Phone: 360-428-2622 | |
Paula Andrade Wolff, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2320 Freeway Dr, Mount Vernon, WA 98273 Phone: 360-814-6850 Fax: 360-814-6920 | |
Ann D Barshney, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1400 E Kincaid St, Mount Vernon, WA 98274 Phone: 360-428-2500 Fax: 360-428-6485 | |
Kara Joan Hawker, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 307 S 13th St Ste 300, Mount Vernon, WA 98274 Phone: 360-336-9757 Fax: 360-814-5237 | |
Emma Mary Hamilton, ARNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1420 Roosevelt Ave Ste 4, Mount Vernon, WA 98273 Phone: 360-899-4086 Fax: 360-899-4124 |